$TAC Signal | Callback Entry: 4H trend not exhausted, 1H momentum contracting, waiting for a second launch


RSI soared to 77.3, buy and sell order depth ratio 0.54, sell orders clearly thicker than buy orders, but price still consolidating around 0.0129. The upper band of the 4H Bollinger Bands at 0.0127 has been broken, the gap is expanding. The 1H MACD histogram continues to shrink, indicating short-term bullish momentum is temporarily losing strength. Funding rate remains moderate at 0.0249%, open interest stable. Current risk-reward ratio is about 1:3, with wide stop-loss, so light positions are recommended. Wait for a pullback confirmation before entering more safely.

๐ŸŽฏDirection: Long (callback entry)

โšกEntry/Order: 0.012838 (recommended upper limit of entry zone)

๐Ÿ›‘Stop-loss: 0.008756

๐Ÿš€Target 1: 0.013450

๐Ÿš€Target 2: 0.015014

๐Ÿ›กTrade management: After reaching Target 1, reduce position by 50%, move stop-loss up to 0.012838 to break even. If the price directly breaks below 0.0126, abandon this plan.

Depth logic: 4H MACD opening upward indicates the medium-term trend is still driven by funds. The divergence at 1H level has not yet formed, just high-level stagnation. Waiting for the price to pull back to the EMA20 (about 0.0116 on 1H) to the 0.0128 range is a reasonable second entry point. If it directly breaks through 0.0132, the probability of success for chasing longs decreases; better to place orders to catch a pullback.

Check real-time market ๐Ÿ‘‡ $TAC
---
Follow me: Get more real-time analysis and insights on the crypto market! $BTC $ETH $SOL
โ€#WCTCไบคๆ˜“็Ž‹PK #ๅŠ ๅฏ†ๅธ‚ๅœบๅฐๅน…ไธ‹่ทŒ #Polymarketๆฏๆ—ฅ็ƒญ็‚น
BTC-1.08%
ETH-0.69%
SOL-0.81%
View Original
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments